Wells Fargo & Company Clear Point Neuro, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 25 shares of CLPT stock, worth $318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 6,970
99.64%
Holding current value
$318
Previous $47,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CLPT
# of Institutions
85Shares Held
7.03MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$15.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.93 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$5.91 Million0.97% of portfolio
-
Cm Management, LLC375KShares$4.78 Million1.88% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$4.77 Million2.12% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $312M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...